Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix
Jeng Yih Wu1, Hong Lu, Yubo Sun
1Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas 77030, USA.
Abstract:
Helicobacter pylori infection and elevated expression of tissue matrix metalloproteinase 1 (MMP-1) are both associated with gastric cancer. We investigated the regulation of MMP-1 expression during H. pylori infection. Real-time reverse transcription-PCR was used to examine mucosal MMP-1 mRNA levels in 55 patients with gastric cancers and 61 control patients. Increased MMP-1 mRNA levels in the gastric mucosa and epithelial cells were observed in H. pylori infections in which both the cag pathogenicity island (PAI) and outer inflammatory protein A (OipA) were expressed. The combined induction of c-fos, c-jun, and polyoma enhancing activator-3 (pea-3) by H. pylori caused maximal increase in MMP-1 expression. Activation of the MMP-1 promoter by H. pylori involved occupation of the activator protein 1 (AP-1) sites at -72 and -181 and, surprisingly, vacancy of the -88 PEA-3 site. Electrophoretic mobility shift, supershift, and chromatin immunoprecipitation assays showed increased binding of c-Fos and c-Jun to the -72 and -181 AP-1 sites during H. pylori infection. Importantly, during wild-type H. pylori infection, we detected increased PEA-3 binding to the -72AP-1 site and decreased PEA-3 binding to the -88 PEA-3 site. However, during infection with the cag PAI and oipA mutants, PEA-3 binding to the -88 site was detected. MMP-1 and pea-3 activities are increased in gastric cancers. Maximal activation of MMP-1 transcription requires the cag PAI and OipA, which regulate AP-1 and PEA-3 binding. Thus, cag PAI and OipA provide a possible link between bacterial virulence factors and important host factors related to disease pathogenesis.
Insights
Helicobacter pylori infection, particularly with cag PAI and OipA, drives gastric cancer by increasing MMP-1 expression. This involves complex regulation of AP-1 and PEA-3 transcription factors, linking bacterial virulence to host factors in disease.
Area of Science:
- Gastroenterology
- Molecular Biology
- Oncology
Background:
- Helicobacter pylori infection is a known risk factor for gastric cancer.
- Elevated matrix metalloproteinase 1 (MMP-1) expression is associated with gastric cancer development.
Purpose of the Study:
- To investigate the regulatory mechanisms of MMP-1 expression during H. pylori infection.
- To elucidate the role of bacterial virulence factors in modulating host gene expression related to gastric cancer.
Main Methods:
- Real-time reverse transcription-PCR to quantify MMP-1 mRNA levels in gastric mucosa.
- Electrophoretic mobility shift, supershift, and chromatin immunoprecipitation assays to analyze transcription factor binding.
- Investigation of H. pylori strains with specific virulence factor mutations (cag PAI and OipA).
Main Results:
- H. pylori infection, especially with cag PAI and OipA, significantly increased MMP-1 mRNA levels in gastric mucosa and epithelial cells.
- Maximal MMP-1 induction was linked to the combined upregulation of c-fos, c-jun, and pea-3.
- H. pylori modulated the binding of transcription factors AP-1 and PEA-3 to the MMP-1 promoter, with cag PAI and OipA playing critical roles.
Conclusions:
- The cag pathogenicity island and outer inflammatory protein A of H. pylori are crucial for maximal MMP-1 activation.
- These bacterial factors influence AP-1 and PEA-3 binding, establishing a link between bacterial virulence and host factors in gastric cancer pathogenesis.
- Increased MMP-1 and pea-3 activity observed in gastric cancers highlights their potential role in disease progression.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Abnormal Proliferation
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors


